Key Details
Last Dividend
$0.05Annual ROE
1.82%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 24, 2023Recent annual earnings:
Feb 24, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 18, 2022Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with SWCH included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Similar stocks
Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces a shift in its corporate strategy to focus on the development of its proprietary technology platform as a prospective Rx-to-OTC switch solution across a multitude of conditions and existing Rx only therapies. If this Software as a Service ("SaaS") and Software as a Medical Device (SaMD) concept is ultimately approved by the FDA, it could significantly serve the emerging self-care market currently estimated to be valued over $38 billion with an expected compounded annual growth rate of 5.6% over the next 10 years.
All amounts in Canadian dollars unless otherwise stated. VANCOUVER, BC / ACCESSWIRE / November 21, 2024 / RE Royalties Ltd.
FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2 clinical study evaluating the investigational combination of islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class HIV-1 capsid inhibitor. These late-breaking data were presented during an oral session at IDWeek 2024, t.
SUNNYVALE, Calif.--(BUSINESS WIRE)--AOZ1390DI-01 and AOZ1390DI-02 Ideal Diode Protection Switches for Multiport USB-C Applications.
The company's fiscal-first quarter earnings will likely be lackluster, J.P. Morgan says.
Nike stock is higher Friday after the embattled retailer announced a 32-year company veteran will return as its incoming CEO. Here's what that means for investors.
Artis REIT is deleveraging and heading in the right direction. Q2 2024 results show improvement in revenues, NOI, FFO, and AFFO. We go over the results and tell you why the higher yielding preferred shares are better despite less promising reset terms.
Anyone who's read my commentary about AMC Entertainment (NYSE: AMC ) in recent years knows I'm as bearish as they come regarding AMC stock. As a result, some even send me hate emails.
Marvell ® Teralynx ® 10 switch now available in Linux Foundation's open-source SONiC, capitalizing on market shift to open network platforms SANTA CLARA, Calif. , July 25, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced the immediate availability of the Marvell ® Teralynx® 10 51.2 Tbps Ethernet switch device in the Linux Foundation's SONiC (Software for Open Networking in the Cloud) network operating system.
NORTHVILLE, Mich. , July 16, 2024 /PRNewswire/ -- As the automotive industry continues to shift to an electrified future, innovation is more important than ever to support automakers seeking to simplify thermal management systems while enhancing vehicle efficiency and range.
FAQ
- What is the primary business of Switch?
- What is the ticker symbol for Switch?
- Does Switch pay dividends?
- What sector is Switch in?
- What industry is Switch in?
- What country is Switch based in?
- When did Switch go public?
- Is Switch in the S&P 500?
- Is Switch in the NASDAQ 100?
- Is Switch in the Dow Jones?
- When was Switch's last earnings report?
- When does Switch report earnings?